Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study of SBRT as Treatment for Oligometastases in Prostate Cancer

NCT02192788 is registered in ClinicalTrials.gov with Grupo de Investigación Clínica en Oncología Radioterapia as lead sponsor.

NCT NCT02192788
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02192788 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study of SBRT as Treatment for Oligometastases in Prostate Cancer
Lead sponsor
Grupo de Investigación Clínica en Oncología Radioterapia
Phase
Not applicable
Overall status
Completed
Start date
August 31, 2014
Completion date
July 31, 2021
Enrollment
68 (actual)
Sites
22

Conditions

As the registry lists them; a condition with its own page is linked.

oligometastatic prostate cancer